HIV resistance survey shows majority of physicians choose single protease inhibitor as first-line combination therapy.
D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000008:administration & dosage*; D006801:Humans; D010818:Practice Patterns, Physicians'; D014481:United States
D017320:HIV Protease Inhibitors